Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
Related Posts
Trump’s tariffs are expected to raise consumer prices, but a key question remains: By how much?
As the U.S. president weighs increasing tariffs on imports, economists find that prices across many categories could rise as a result.
Figma confidentially files for IPO more than a year after ditching Adobe deal
Figma, whose software is widely used among app designers, appears headed for the public market after abandoning a tie-up with Adobe in 2023.
Elon Musk’s favorability among Republicans dropped 16 points since March, Quinnipiac says
The Tesla CEO’s favorability scores have declined among GOP voters, according to public opinion survey results from Quinnipiac University.